| Molecular and clinical outcomes after intravenous gentamicin treatment for patients with junctional epidermolysis bullosa caused by nonsense variants D Mosallaei, M Hao, RJ Antaya, B Levian, A Kwong, J Cogan, C Hamilton, ... JAMA dermatology 158 (4), 366-374, 2022 | 27 | 2022 |
| Aged mice demonstrate greater muscle degeneration of chronically injured rotator cuff AK Sharma, B Levian, P Shah, GM Mosich, R Husman, A Ariniello, ... Journal of Orthopaedic Research® 38 (2), 320-328, 2020 | 21 | 2020 |
| Why Are There So Few FDA-Approved Therapeutics for Wound Healing? M Chen, C Chang, B Levian, DT Woodley, W Li International Journal of Molecular Sciences 24 (20), 15109, 2023 | 14 | 2023 |
| Incidence of injuries among lacrosse athletes: a systematic review and meta-analysis LK Hasan, T Shelby, IK Bolia, T Chu, N Trasolini, FA Padilla, B Levian, ... The Physician and Sportsmedicine 51 (2), 158-165, 2023 | 7 | 2023 |
| Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial DT Woodley, M Hao, A Kwong, B Levian, J Cogan, Y Hou, D Mosallaei, ... British Journal of Dermatology, ljae063, 2024 | 5 | 2024 |
| Pseudopemphigoid: A systematic review B Levian, SS Hussaini, DT Woodley, M Kasperkiewicz JAAD international 17, 170-171, 2024 | 2 | 2024 |
| Out of REACH: Allergic contact dermatitis to nickel in an Apple Watch B Levian, GC Chan, BL Adler Contact Dermatitis 90 (1), 99-101, 2024 | 2 | 2024 |
| Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosa B Levian, Y Hou, X Tang, L Bainvoll, K Zheng, V Badarinarayana, ... Molecular Therapy Nucleic Acids 35 (4), 2024 | 1 | 2024 |
| Patch Testing and Immunosuppression: a Comprehensive Review B Levian, J Chan, VA DeLeo, BL Adler Current Dermatology Reports, 1-12, 2021 | 1 | 2021 |
| 756 Enhancing readthrough therapy for epidermolysis bullosa: The synergistic potential of SRI-41315 and gentamicin Y Hou, B Levian, C Chung, D Woodley, M Chen Journal of Investigative Dermatology 144 (8), S132, 2024 | | 2024 |
| 405 CC-90009 potentiates gentamicin-induced premature termination codon readthrough activity in epidermolysis bullosa B Levian, Y Hou, C Chung, R Filzen, K Zheng, M Chen Journal of Investigative Dermatology 144 (8), S70, 2024 | | 2024 |
| Serological response to SARS-CoV-2 vaccination in patients with immunobullous diseases B Levian, S Tukaj, DT Woodley, M Kasperkiewicz JEADV Clinical Practice, 2024 | | 2024 |
| A Rapidly Enlarging Facial Abscess B Levian, A Chen, BL Adler JAMA dermatology 158 (10), 1205-1206, 2022 | | 2022 |
| 849 Optimization of intravenous gentamicin to restore functional laminin 332 in junctional epidermolysis bullosa patients harboring nonsense mutations BA Levian, D Mosallaei, R Antaya, D Woodley, M Chen Journal of Investigative Dermatology 142 (8), S147, 2022 | | 2022 |
| 498 Artesunate inhibits RDEB fibrosis by downregulating AKT signaling pathway D Woodley, D Polyakov, BA Levian, Y Hou, X Tang, M Chen Journal of Investigative Dermatology 142 (8), S84, 2022 | | 2022 |
| Immunobullous diseases with ear involvement: A systematic review SS Hussaini, B Levian, B Wrobel, DT Woodley, M Kasperkiewicz JEADV Clinical Practice, 0 | | |
